NCT01181284 Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) Status COMPLETED Phase N/A
NCT01179737 Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE2
NCT01172496 A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01165476 Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities Status COMPLETED Phase PHASE1
NCT01153386 Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine Status COMPLETED Phase PHASE1
NCT01131845 The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil Status COMPLETED Phase PHASE1
NCT01117987 Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE3
NCT01105117 Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 Status COMPLETED Phase PHASE4
NCT01105091 Epoprostenol for Injection in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT01100736 Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3) Status COMPLETED Phase EARLY_PHASE1
NCT01094067 Tezosentan in Patients With Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE2
NCT01092559 Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide Status COMPLETED Phase PHASE2
NCT01066845 Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT01054105 Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension Status COMPLETED Phase N/A